Company Expansion / M&A / Business Partnership / FDA Phase / Funding / Product Issues / /
Facility
Molecular Profiles Ltd Two University of Nottingham / SWiNG reactor / Nottingham City Hospital / The University of Nottingham’s School / University Architecture / University of Nottingham / The University of Nottingham / University of Oxford / Technology Transfer The Sir Colin Campbell Building The University of Nottingham Innovation Park / Queen’s Medical Centre / /
IndustryTerm
analytical and development solutions / software builds / niche expertise and technologies / expert consultancy / technology medicine / pharmaceutical industry / biotechnology industries / large multinational pharmaceutical / treatment of growth failure / large pharmaceutical / food flavour assessment / resource management / resolution imaging systems / sustainable energy research / art algorithms / technology transfer services / sustainable product / resource planning solutions / continuous hydrothermal synthesis technology / food / manufacturing process / energy / pharmaceutical development services / workforce management solutions / models and services / treatment of melanoma / multifunction device / electrophysiological systems / treatment of cancer / biotechnology businesses / manufacturing / acquired nitrogen fixation technology / pharmaceutical development / technology development research / biotechnology / medical devices / sustainable solution / biological drug products / pharmaceutical / nitrogen fixing bacteria / project management / long acting injectable products / biopharmaceutical / service incorporating cutting edge technology / food security / drug delivery technologies / natural nitrogen fixation technology / wearable device / using electrophysiological systems / /
MedicalCondition
strokes / HIV / chronic infectious diseases / skin cancer / melanoma / hepatitis / breast cancer / endometrio cancer / cancer / osteoporosis / spin-out Scancell Scancell’s first cancer / women-related cancers / tumours / common cancers / heart attacks / unique patient relevant and predictive cancer / prognostic breast cancer / breast cancers / tumour / lung cancer / /
MedicalTreatment
vaccination / surgery / gynaecological surgery / /
Organization
University of Nottingham’s School of Pharmacy / University’s Faculty of Engineering / University of Oxford / University of Nottingham Innovation Park / FDA / University’s School of Chemical and Environmental Engineering / £40m Enterprise Capital Fund / Nottingham University / University’s School of Electrical and Electronic Engineering / Nottingham City Hospital / Nottingham Technology Fund / University of Nottingham / Department of Obstetrics / Queen’s Medical Centre / /
Person
Nikin Patel / Martyn Davies / David Greenaway / Susan Huxtable / Philip Stone / Clive Roberts / Barrie Hayes-Gill / Peter Mansfield / Jonathan Lloyd Jones / Phil Williams / Frank C. Condella / Jr. / Professors Martyn Davies / Saul Tendler / Locate Therapeutics / Lindy Durrant / Bruce Venning / / /
Position
CTO / Director / Intellectual Property Commercialisation Tel / CEO / Professor / Director of Intellectual Property Commercialisation / President and CEO / Commercial Manager / Technology Transfer Tel / Laparoscopic Assistant / Vice-Chancellor / leader / Chairman / specialist business unit / international leader in research / President & CFO / /